CXCL9 and diabetes mellitus: Preclinical studies have highlighted the potential of mesenchymal stem cells to attenuate pancreatic islet infiltration by T-cells and CXCL9 + macrophages, reducing the incidence of ICI-DM in murine models;[33] However, human trials are pending.